본문 바로가기
KERD
논문KCI 등재

Erratum : Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis

0

조회

0

다운로드

0

인용

0

참고문헌

초록

In the article entitled “Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis,” there was an error in Results section of the abstract. In the sentence “In the severe patients, the incidence of thromboembolic and bleeding events in the therapeutic or intermediate.” should be: “In the severe group, the incidence of thromboembolic and bleeding events in the thera- peutic and prophylaxis groups was not statistically different.” Furthermore, the city of Myongji Hospital was inadvertently omitted, and it should be in- cluded as “Goyang.”

관련 논문AI추천

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis김정현, 장혜진, 조준성, 최원일, Choi Miyoung, Lee Hyeon-Jeong, Park Jungeun대한중환자의학회 · Acute and Critical Care2023 · 제38권 제2호Erratum : Current Anticoagulant Usage Patterns and Determinants in Korean Patients with Nonvalvular Atrial Fibrillation김준, 강기운, 김중민, 김진배, 김창수, 김태훈, 박준범, 박진규, 박형욱, 심재민, 엄재선, 이영수, 이정명, 정보영, 차명진, 최의근, 하현수연세대학교의과대학 · Yonsei Medical Journal2021 · 제62권 제10호COVID-19 중환자에서 예방적 항응고제 사용 및 출혈 관련 약물이상반응 발생 현황 보고김형숙, 방선아, 이정화, 이주연, 정영미, Eunkyung Euni Lee한국병원약사회 · 병원약사회지2022 · 제39권 제2호Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillationHyung Wook Park, Ki Hong Lee대한내과학회 · The Korean Journal of Internal Medicine2023 · 제38권 제5호암환자의 정맥혈전색전증 치료에서 rivaroxaban과 dalteparin의 출혈 부작용 비교곽혜선, 김윤경, 김재연, 안숙희, 정지은한국임상약학회 · 한국임상약학회지2016 · 제26권 제3호내과 중환자에서 정맥혈전증의 예방법으로서 Enoxaparin과 Unfractionated heparin의 효과 및 안전성 비교박효정, 유재영, 이영미, 인용원, 최유리한국병원약사회 · 병원약사회지2012 · 제29권 제2호

이 간행물의 다른 논문 (16건)